Ghost Tree Capital, LLC Leap Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

  • $310 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.96 - $1.91 $953,965 - $1.9 Million
-993,714 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.6 - $3.35 $570,057 - $1.19 Million
-356,286 Reduced 26.39%
993,714 $1.74 Million
Q4 2021

Feb 16, 2022
SELL
$2.08 - $3.65 $624,000 - $1.1 Million
-300,000 Reduced 18.18%
1,350,000 $4.37 Million
Q3 2021

Nov 15, 2021
BUY
$1.35 - $4.01 $2.23 Million - $6.62 Million
1,650,000 New
1,650,000 $6.62 Million

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0
View Full List

About LEAP THERAPEUTICS, INC.

LPTX Quotes by TradingView
  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $198M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email